Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


AstraZeneca AB

Division of AstraZeneca PLC

Latest From AstraZeneca AB

Supreme Court And Patents: What’s Not Happening

High court denies petition by Mylan to limit patent litigation venue and petition by Merck KGAA to address whether “on sale” bar to obtaining patent applies to non-public sales; Zarxio case to go to conference Friday.

BioPharmaceutical Policy

Mylan Wants Supreme Court To Limit Patent Litigation Venue

Federal Circuit decision permits brand-name drug makers to file infringement suits against generic manufacturers in whatever jurisdiction they wish.

BioPharmaceutical Policy

Have Patent, Will Travel: Brand Firms Can File Infringement Suits Anywhere

Federal Circuit denies Mylan's bid to dismiss litigation in Delaware; PhRMA, BIO and Teva argued that brand manufacturers should be allowed to sue multiple generic manufacturers in a single forum.

BioPharmaceutical United States

OTC Branding Distinction Could Gain From Recent Rx Trademark Litigation

AstraZeneca wins a temporary restraining order preventing Dr. Reddy’s from marketing an all-purple generic of the proton pump inhibitor Nexium. OTC switch application consultant Susan Lavine Coleman says the decision “sends a strong warning to future OTC private label manufacturers”

BioPharmaceutical Consumer
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Scandinavia
          • Sweden
  • Parent & Subsidiaries
  • AstraZeneca PLC
  • Senior Management
  • Contact Info
  • AstraZeneca AB
    Phone: 8 553 260 00
    Karlebyhus, Astraallén
    Södertälje, SE-151 85